Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Insight Genetics Inks Deal with St. Jude Children’s Research Hospital

Published: Monday, October 07, 2013
Last Updated: Monday, October 07, 2013
Bookmark and Share
Company announced it has entered into an exclusive, worldwide licensing agreement with the hospital for a genetic test known as the KIR/KIR-Ligand Assay.

The test helps to predict the success of bone marrow transplants by identifying the optimal bone marrow donor subtype. Use of the KIR/KIR-Ligand Assay has been shown to prevent the return of cancer in transplant recipients and reduce risk of death following bone marrow transplantation by about 60 percent. As part of the agreement, Insight Genetics will optimize the KIR/KIR-Ligand Assay for rapid, high-capacity use and make it broadly available to physicians and their patients as well as donor registries.

“When successful, bone marrow transplants can transform patients’ lives,” said Wing Leung, MD, PhD, Chair of St. Jude’s Department of Bone Marrow Transplantation and Cellular Therapy. “This is why it’s critical we do everything we can to ensure the best match between donor and recipient. The KIR/KIR-Ligand Assay has great potential in helping to identify the best transplant donors and improve outcomes for patients worldwide.”

The U.S. Health Resources and Services Administration estimates that each year more than 18,000 Americans are diagnosed with life-threatening illnesses for which bone marrow transplants are the best treatment option. There are millions of individuals registered as potential bone marrow donors, but effectively matching a patient in need of a transplant with the right donors is a difficult process.

According to the World Health Organization, when donors and recipients are optimally matched, bone marrow transplants can cure more than 90 percent of patients with blood and lymph cancers. The KIR/KIR-Ligand Assay has the potential to make the screening process more efficient and effective, greatly increasing the volume and quality of the donor-patient match. In fact, it is estimated that the test could assist in improving donor matches and increasing life expectancy for as many as 7,500 bone marrow transplant patients in the U.S. annually.

The KIR/KIR-Ligand test was developed by Dr. Leung, Dr. Rafijul Bari and colleagues at St. Jude as part of their research to determine the impact of variations in the KIR2DL1 gene. The group focused on forms of KIR2DL1 carried by natural killer (NK) cells, special immune cells that kill abnormal cells such as cancer cells. Their research found that some forms of KIR2DL1 in NK cells are more active than others, and NK cells carrying the stronger form of KIR2DL1 can destroy cancer cells more effectively than the NK cells with the less active form.

A study conducted by Bari, Leung and colleagues that was featured in the September 16 online version of the Journal of Clinical Oncology (JCO) showed that patients were much more likely to survive a transplant and significantly less likely to experience disease progression when bone marrow transplants came from donors whose NK cells included the stronger form of KIR2DL1.

“The KIR/KIR-Ligand technology developed at St. Jude offers enormous potential to improve the lives of patients who receive bone marrow transplants, and we’re looking forward to putting our assay development expertise to work to make it available for widespread clinical use around the world,” said David Hout, PhD, Vice President of Research and Development at Insight Genetics. “With this assay, we have the ability to type multiple donor samples simultaneously and generate results rapidly, all at a reduced cost compared to existing screening methods. This test will not only increase the efficiency with which transplants are performed but it also promises to help dramatically improve cure rates by optimally matching each donor and recipient.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
Insight Genetics has developed a diagnostic test that can more accurately determine if certain lung cancer patients will respond to targeted therapies.
Tuesday, April 02, 2013
Insight Genetics Awarded Qualifying Therapeutic Discovery Program Grant
Diagnostics Company Receives Funds to Advance Cancer Care.
Wednesday, November 17, 2010
Scientific News
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
HPV Genomes Show Greater Diversity Than Expected in Cancer Patients
The findings could have implications for eventually understanding why some cervical lesions become malignant.
Rapidly Detecting Drug-Resistant HepC
A nested PCR-based assay has been shown to rapidly and accurately detect drug-resistant strains of the hepatitis C virus.
Researchers Seek Water Test for Invasive Species Detection
Detecting invasive lake and river species using just a water sample would be a dream come true for wildlife managers and regulators in the state and University of Maine researchers may soon make this an inexpensive reality.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Profiling DNA Viruses in Arctic Lakes
The Arctic's freshwater lakes contain viral communities composed of DNA viruses from lineages that are largely distinct from those described elsewhere, a new study suggests.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!